In particular, leptin induces breast cancer stemness and resistance to chemotherapy [75], through complex mechanisms that comprise signaling cross talk between Notch, IL-1, and leptin (NILCO) [76] and epigenetic downregulation of miR-200c in TNBC cells [77]. The gene discussed is LEP; the disease is breast carcinoma.